Press Releases

Press Releases

11.06.19
OpGen Reports Third Quarter 2019 Financial Results and Provides Business Update
11.04.19
OpGen Provides Update on Curetis Group Company Ares Genetics Business
10.29.19
OpGen Announces Date of Third Quarter 2019 Financial Results Conference Call
10.28.19
OpGen Announces Closing of $9.4 Million Underwritten Public Offering
10.23.19
OpGen Announces Pricing of $9.4 Million Underwritten Offering
10.23.19
U.S. Patent Allowed Covering Acuitas Lighthouse® Software
10.07.19
OpGen Presents Preliminary Acuitas® AMR Gene Panel Data for Detecting Urinary Tract Infections
09.26.19
OpGen to Present on Guiding Precision Antibiotic Therapy with Rapid Genomics and Informatics at IDWeek 2019
09.18.19
OpGen Provides update on Curetis Group’s R&D Collaboration
09.04.19
Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses